Medication for Opioid Use Disorder (MOUD) helps people reduce or quit their use of heroin or other opiates. Qualified physicians, advanced nurse practitioners and physician assistants are required to acquire a waiver (commonly known as the x-waiver) and maintain certifications to legally dispense or prescribe opioid use disorder medications to more than 30 patients. Idaho desperately needs more providers to offer this important treatment in their practice.
Free X-Waiver Training hosted by ECHO Idaho
ECHO Idaho, in conjunction with Providers Clinical Support System (PCSS), hosts trainings for physicians, advanced nurse practitioners and physician assistants who want to get their x-waiver to prescribe and dispense buprenorphine to more than 30 patients. Sessions are also open to non-waiver seekers who wish to audit the training.
Our 2022 X-Waiver Trainings will be held 11:30 a.m. to 4 p.m. Pacific time / 12:30 - 5 p.m. Mountain time on the following dates:
- Monday, February 7, 2022
- Monday, June 20, 2022
- Monday, September 19, 2022
The two-part training includes:
- A live 4-hour training, which participants can join from anywhere in the state using Zoom. Participants must be able to join using a webcam.
- Online modules you complete on your own. The link to the online portion will be sent to those who complete all four hours of the live training.
Physicians who complete the eight-hour training will be eligible to apply for the waiver to prescribe and dispense buprenorphine to more than 30 patients. Advanced nurse practitioners and physician assistants will also be eligible to apply for the waiver after an additional 16 hours of training.
At the conclusion of this activity participants should be able to:
- Review addiction treatment in office- based practices
- Discuss the pharmacological treatments of opioid use disorder
- Determine what medical record documentation must be followed
- Discuss the process of buprenorphine induction as well as stabilization and maintenance techniques
- Describe how to take a patient history and evaluation
- Review safety concerns and drug interactions
Dr. Magni Hamso, MD, MPH, FACP, FASAM
Medical Director, Division of Medicaid, Idaho Department of Health & Welfare
Core Faculty, University of Washington - Boise Addiction Medicine Fellowship; Clinical Assistant Professor, University of Washington; Staff Physician, Boise VA Medical Center
Dr. Todd Palmer, MD
Medical Director, Addiction Medicine Fellowship and Geriatric Medicine Fellowship, Family Medicine Residency of Idaho
Assistant Professor in Family Medicine, University of Washington
The live, four hour training credit is commensurate with the extent of your participation in 0.25 credits. The online modules are not eligible for partial credit; completing all four hours is required to receive credit.
Accreditation – Online Portion
The American Academy of Addiction Psychiatry is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), the American Academy of PAs (AAPA), American Psychological Association (APA) and Association for Social Work Boards (ASWB) to provide continuing education for the healthcare team.
The online portion of this training will receive 4 CE credits. CME will be provided not only to physicians, but also CE for nurses, pharmacists, physician assistants as well as interprofessional CE credits. No partial credit will be awarded.
Please see the Joint Accreditation flyer in the Related Links section for more information.
Accreditation – Live Portion
The University of Idaho, WWAMI Medical Education Program is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Idaho, WWAMI Medical Education Program designates this live activity for a maximum of 4.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAAP is the Data Sponsor for this training.
Funding for this initiative was made possible (in part) by grant no. 1H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
ECHO Idaho is led by the University of Idaho, the WWAMI Medical Education Program, and its X-Waiver training program is supported in part under Grant No. 2018-PM-BX-K123 awarded by the Bureau of Justice Assistance. The Bureau of Justice Assistance is a component of the Department of Justice’s Office of Justice Programs, which also includes the Bureau of Justice Statistics, the National Institute of Justice, the Office of Juvenile Justice and Delinquency Prevention, the Office for Victims of Crime, and the SMART Office. Points of view or opinions in this document are those of the author and do not necessarily represent the official position or policies of the U.S. Department of Justice.